BASIS OF PRESENTATION (Details) ¥ in Thousands				3 Months Ended		6 Months Ended		9 Months Ended		12 Months Ended
	Dec. 07, 2020 USD ($)	Jun. 30, 2020 USD ($) shares	Jan. 19, 2017 USD ($) shares	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Jun. 30, 2018 CNY (¥)	Jun. 30, 2019 USD ($)	Dec. 31, 2018
BASIS OF PRESENTATION (Details) [Line Items]
Stock Issued During Period, Shares, Acquisitions (in Shares) | shares			16,155,746,000
Proceeds from Sales of Business, Affiliate and Productive Assets			$ 100
Equity Method Investment, Ownership Percentage										49.00%
Payments to Acquire Interest in Joint Venture | ¥										¥ 2,450
Net Income (Loss) Attributable to Parent				$ (13,417,001)	$ (2,741)	$ (38,939)	$ (15,311)	$ (13,455,941)	$ (18,052)
Net Cash Provided by (Used in) Operating Activities								(97,025)	(17,108)
Stockholders' Equity Attributable to Parent		$ (215,007)		(296,611)	$ (361,882)	$ (250,829)	$ (180,941)	(296,611)	$ (361,882)		$ (168,002)
Cash		$ 166		$ 25,253				$ 25,253
Corporate Joint Venture [Member]
BASIS OF PRESENTATION (Details) [Line Items]
Equity Method Investment, Ownership Percentage	60.00%											49.00%
Payments to Acquire Interest in Joint Venture	$ 4,200,000
Noncontrolling Interest in Joint Ventures	$ 29,800,000
Corporate Joint Venture [Member] | Brilliant Healthcare Limited [Member]
BASIS OF PRESENTATION (Details) [Line Items]
Equity Method Investment, Ownership Percentage	40.00%
Purecell Group [Member]
BASIS OF PRESENTATION (Details) [Line Items]
Stock Issued During Period, Shares, Acquisitions (in Shares) | shares		510,000,000
Equity Method Investment, Ownership Percentage		51.00%